Michael Perelman

424 total citations
21 papers, 330 citations indexed

About

Michael Perelman is a scholar working on Anesthesiology and Pain Medicine, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Perelman has authored 21 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Anesthesiology and Pain Medicine, 7 papers in Pediatrics, Perinatology and Child Health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Perelman's work include Pain Management and Opioid Use (9 papers), Pediatric Pain Management Techniques (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Michael Perelman is often cited by papers focused on Pain Management and Opioid Use (9 papers), Pediatric Pain Management Techniques (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Michael Perelman collaborates with scholars based in United Kingdom, United States and Spain. Michael Perelman's co-authors include Alan M. Smith, Michael Hinchcliffe, D M Krikler, Edward Rowland, William J. McKenna, Peter Watts, Alastair D. Knight, Ben Simmons, Jonathan Castile and Yuhui Cheng and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Pharmacology and Experimental Therapeutics and Heart.

In The Last Decade

Michael Perelman

21 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Perelman United Kingdom 9 84 68 57 41 40 21 330
Eun Hye Lee South Korea 8 15 0.2× 131 1.9× 113 2.0× 22 0.5× 10 0.3× 26 347
Mohammad Abdallah Saudi Arabia 10 15 0.2× 26 0.4× 81 1.4× 8 0.2× 48 1.2× 25 364
Annelieke C. Kruithof Netherlands 10 18 0.2× 168 2.5× 53 0.9× 11 0.3× 40 1.0× 20 347
Kohei Togami Japan 14 9 0.1× 66 1.0× 88 1.5× 14 0.3× 13 0.3× 43 473
Seung‐Hyun Lee South Korea 9 24 0.3× 7 0.1× 65 1.1× 16 0.4× 26 0.7× 20 272
J. M. Robson United Kingdom 13 49 0.6× 9 0.1× 69 1.2× 37 0.9× 3 0.1× 46 420
Nabil Al‐Tawil Sweden 11 6 0.1× 24 0.4× 112 2.0× 9 0.2× 33 0.8× 22 407
Sunita Jain India 4 8 0.1× 18 0.3× 97 1.7× 6 0.1× 13 0.3× 10 368
Hiroo Ishii Japan 9 208 2.5× 6 0.1× 141 2.5× 16 0.4× 8 0.2× 17 482
Mohammed Bouhajib United States 7 14 0.2× 32 0.5× 42 0.7× 11 0.3× 30 0.8× 16 206

Countries citing papers authored by Michael Perelman

Since Specialization
Citations

This map shows the geographic impact of Michael Perelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Perelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Perelman more than expected).

Fields of papers citing papers by Michael Perelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Perelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Perelman. The network helps show where Michael Perelman may publish in the future.

Co-authorship network of co-authors of Michael Perelman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Perelman. A scholar is included among the top collaborators of Michael Perelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Perelman. Michael Perelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dicpinigaitis, Peter V., Brendan J. Canning, Robert J. DeVita, et al.. (2017). The antitussive effects of alpha7 (α7) nicotinic receptor agonists. OA4409–OA4409. 6 indexed citations
3.
Ueberall, Michael A., et al.. (2016). Efficacy, safety, and tolerability of fentanyl pectin nasal spray in patients with breakthrough cancer pain. Journal of Pain Research. Volume 9. 571–585. 13 indexed citations
4.
Torres, L. M., et al.. (2015). Fentanyl pectin nasal spray for breakthrough cancer pain. International Journal of Palliative Nursing. 21(3). 114–116. 1 indexed citations
5.
Burton, Allen W., et al.. (2014). An analysis of the variability of breakthrough pain intensity in patients with cancer. The Journal of Community and Supportive Oncology. 12(3). 99–103. 1 indexed citations
6.
Torres, L. M., et al.. (2014). Relationship between Onset of Pain Relief and Patient Satisfaction with Fentanyl Pectin Nasal Spray for Breakthrough Pain in Cancer. Journal of Palliative Medicine. 17(10). 1150–1157. 8 indexed citations
7.
Torres, L. M., et al.. (2014). Relationship between performance status and satisfaction with fentanyl pectin nasal spray. Revista de la Sociedad Española del Dolor. 21(4). 191–196. 1 indexed citations
8.
Perelman, Michael, A.N. Fisher, Alan Smith, & Alastair D. Knight. (2013). The impact of allergic rhinitis and its treatment on the pharmacokinetics of nasally administered fentanyl. International Journal of Clinical Pharmacology and Therapeutics. 51(5). 349–356. 15 indexed citations
9.
Smith, Alan M., Michael Perelman, & Michael Hinchcliffe. (2013). Chitosan. Human Vaccines & Immunotherapeutics. 10(3). 797–807. 115 indexed citations
10.
Taylor, Donald R., et al.. (2013). A Report on the Long-Term Use of Fentanyl Pectin Nasal Spray in Patients With Recurrent Breakthrough Pain. Journal of Pain and Symptom Management. 47(6). 1001–1007. 17 indexed citations
11.
Perelman, Michael & Alastair D. Knight. (2013). A pharmacokinetic assessment of an alternate titration strategy for fentanyl pectin nasal spray. International Journal of Clinical Pharmacology and Therapeutics. 51(12). 942–947. 2 indexed citations
12.
Castile, Jonathan, Yuhui Cheng, Ben Simmons, et al.. (2012). Development ofin vitromodels to demonstrate the ability of PecSys®, anin situnasal gelling technology, to reduce nasal run-off and drip. Drug Development and Industrial Pharmacy. 39(5). 816–824. 39 indexed citations
13.
Watts, Peter, Alan M. Smith, & Michael Perelman. (2012). Nasal delivery of fentanyl. Drug Delivery and Translational Research. 3(1). 75–83. 7 indexed citations
14.
Torres, L. M., et al.. (2012). Assessment of the relationship between ECOG score and fentanyl pectin nasal spray acceptability scores for breakthrough pain in cancer.. Journal of Clinical Oncology. 30(15_suppl). e19567–e19567. 1 indexed citations
15.
Endersby, C.A., et al.. (1991). Safety Profile of Lacidipine. Journal of Cardiovascular Pharmacology. 17. S45–47. 6 indexed citations
16.
Perelman, Michael, William J. McKenna, Edward Rowland, & D M Krikler. (1987). A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation.. Heart. 58(4). 339–344. 44 indexed citations
17.
Perelman, Michael & D M Krikler. (1987). Termination of focal atrial tachycardia by adenosine triphosphate.. Heart. 58(5). 528–530. 27 indexed citations
18.
Rowland, Edward, R A Foale, Petros Nihoyannopoulos, Michael Perelman, & D M Krikler. (1985). Intracardiac contrast echoes during transvenous His bundle ablation.. Heart. 53(3). 240–242. 8 indexed citations
19.
Rowland, Edward, William J. McKenna, D Holt, Michael Perelman, & D M Krikler. (1984). ORAL AMIODARONE FOR THE CONVERSION OF ESTABLISHED ATRIAL-FIBRILLATION. UCL Discovery (University College London). 3 indexed citations
20.
Perelman, Michael, Edward Rowland, & D M Krikler. (1984). Assessment of a prototype implantable cardioverter for ventricular tachycardia. Relation between synchronisation of sensing and origin of the tachycardia.. Heart. 52(4). 385–391. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun Hye Lee Breakdown of academic impact, for papers by Mohammad Abdallah Breakdown of academic impact, for papers by Annelieke C. Kruithof Breakdown of academic impact, for papers by Kohei Togami Breakdown of academic impact, for papers by Seung‐Hyun Lee Breakdown of academic impact, for papers by J. M. Robson Breakdown of academic impact, for papers by Nabil Al‐Tawil Breakdown of academic impact, for papers by Sunita Jain Breakdown of academic impact, for papers by Hiroo Ishii Breakdown of academic impact, for papers by Mohammed Bouhajib
Rankless by CCL
2026